CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-20 | Baity Glenn EVP AND GC | Sale | −38,097 | $30.00 | $1.1M | 71,156 |
| 2017-07-20 | Baity Glenn EVP AND GC | Option exercise · Stock Option (right to buy) | −28,097 | 28,000 | ||
| 2017-07-17 | SOLAND DANIEL B Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-07-17 | Daly James M Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-07-17 | HARRIGAN EDMUND Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-06-22 | Baity Glenn EVP AND GC | Option exercise | +1,903 | $1.62 | $3K | 83,059 |
| 2017-06-22 | Baity Glenn EVP AND GC | Sale | −1,903 | $30.00 | $57K | 81,156 |
| 2017-06-22 | Baity Glenn EVP AND GC | Option exercise · Stock Option (right to buy) | −1,903 | 56,097 | ||
| 2017-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2017-06-13 | SOLAND DANIEL B Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-06-13 | Daly James M Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-06-13 | Brege Laura Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-06-13 | HARRIGAN EDMUND Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-05-15 | Baity Glenn EVP AND GC | Option exercise | +14,093 | $1.62 | $23K | 81,156 |
| 2017-05-15 | Baity Glenn EVP AND GC | Option exercise · Stock Option (right to buy) | −14,093 | 58,000 | ||
| 2017-03-29 | YANG MICHAEL J. EVP AND CCO | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2017-03-08 | YOUNG TODD S. EVP AND CFO | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2017-03-08 | Stankovic Srdjan R. EVP | Grant or award · Stock Option (right to buy) | +93,750 | 93,750 | ||
| 2017-03-08 | Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (right to buy) | +33,750 | 33,750 | ||
| 2017-03-08 | Baity Glenn EVP AND GC | Grant or award · Stock Option (right to buy) | +46,875 | 46,875 |
Page 50 of 63 · 1,260 trades